4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Aelis Farma SA (AELIS) operates in the Biotechnology industry and is headquartered in Bordeaux, France with about 16 employees. Its market capitalization is roughly €14 million. In the fiscal year ended 2025-12-31, AELIS reported €0M in revenue and (€6M) in net income.
Aelis Farma SA, a clinical-stage biopharmaceutical company, focuses on discovering and developing drug candidates for the treatment of central nervous system disorders in France.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | €0M | €3M | €9M | €4M |
| Operating Income (EBIT) | (€6M) | (€8M) | (€6M) | (€8M) |
| Net Income | (€6M) | (€8M) | (€5M) | (€14M) |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | €12M | €20M | €26M | €39M | — |
| Total Liabilities | €8M | €10M | €13M | €19M | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive AELIS viewer.
About TickerBase · Data methodology & sources · Privacy · Terms